Literature DB >> 3631916

Loss of pedunculopontine neurons in progressive supranuclear palsy.

R M Zweig, P J Whitehouse, M F Casanova, L C Walker, W R Jankel, D L Price.   

Abstract

In the present study, the number of neurons (greater than 20 microns in diameter) within the lateral part of the pedunculopontine nucleus pars compacta (PPNc) was determined at six rostrocaudal levels in 3 subjects with progressive supranuclear palsy (PSP), in 9 subjects with Alzheimer's disease, and in 6 age-matched control subjects. At each level examined, significantly fewer neurons were present in patients with PSP than in control subjects (49 to 69% reduction). Significant differences in numbers of neurons were not demonstrated between control subjects and patients with Alzheimer's disease. The extent of pathological changes, particularly neurofibrillary tangles, was examined within the PPNc of subjects in these three groups. The average number of neurofibrillary tangles in a 12-microns-thick midlevel section of the lateral PPNc was 68.7 in subjects with PSP, 18.3 in those with Alzheimer's disease, and 3.0 in aged control subjects. These abnormalities of PPNc neurons in PSP may play important roles in some of the clinical features characteristic of this disease.

Entities:  

Mesh:

Year:  1987        PMID: 3631916     DOI: 10.1002/ana.410220107

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

1.  Descending brainstem projections of the pedunculopontine tegmental nucleus in the rat.

Authors:  I Grofova; S Keane
Journal:  Anat Embryol (Berl)       Date:  1991

Review 2.  Progressive supranuclear palsy: clinical features, pathophysiology and management.

Authors:  A Rajput; A H Rajput
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Pedunculopontine stimulation from primate to patient.

Authors:  Erlick A C Pereira; Dipankar Nandi; Ned Jenkinson; John F Stein; Alexander L Green; Tipu Z Aziz
Journal:  J Neural Transm (Vienna)       Date:  2011-03-30       Impact factor: 3.575

4.  Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.

Authors:  Jingjie Ge; Jianjun Wu; Shichun Peng; Ping Wu; Jian Wang; Huiwei Zhang; Yihui Guan; David Eidelberg; Chuantao Zuo; Yilong Ma
Journal:  Hum Brain Mapp       Date:  2018-03-13       Impact factor: 5.038

5.  Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.

Authors:  Raffaele Nardone; Igor Florio; Piergiorgio Lochner; Frediano Tezzon
Journal:  Exp Brain Res       Date:  2005-03-08       Impact factor: 1.972

6.  The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.

Authors:  K Jellinger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

7.  Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.

Authors:  M Asahina; T Suhara; H Shinotoh; O Inoue; K Suzuki; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

8.  The auditory startle response in parkinsonism may reveal the extent but not type of pathology.

Authors:  David R Williams; Louise M F Doyle; Andrew J Lees; Peter Brown
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

9.  Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations.

Authors:  K Wakabayashi; K Oyanagi; T Makifuchi; F Ikuta; A Homma; Y Homma; Y Horikawa; S Tokiguchi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Midbrain atrophy in subcortical ischemic vascular dementia.

Authors:  Young-Hee Sung; Ki-Hyung Park; Yeung-Bae Lee; Hyeon-Mi Park; Dong Jin Shin; Jea-Sul Park; Mi-Sun Oh; Hyeo-Il Ma; Kyung-Ho Yu; Suk-Yun Kang; Yun Joong Kim; Byung-Chul Lee
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.